Experience

Hengrui Pharma and GSK Enter Agreement to Develop up to 12 Medicines

July 27, 2025

Cooley advised Hengrui Pharma, a global pharmaceutical company, on its up to $12.5 billion agreement with GSK to develop up to 12 medicines to complement GSKs extensive respiratory, immunology and inflammation (RI&I) and oncology pipeline.

Read more

Related contacts

Alan W. Tamarelli
Partner, New York
Frances Stocks Allen
Partner, London
Jiqiang Lin
Associate, New York
Freddy Yip
Associate, Hong Kong
Aaron Pomeroy
Partner, Colorado
David Wilson
Partner, London
Dr. Xiaozhen (Shawn) Yu
Partner, Washington, DC
Julia R. Brinton
Special Counsel, Washington, DC
David Burns
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Robert Eisenbach
Of Counsel, San Francisco
Navya Dasari
Associate, New York
Rick Jantz
Associate, Santa Monica
Eerik Kukebal
Associate, London
Daniel Millard
Associate, London
Patrick Sharma
Associate, Santa Monica
Zhijing Yu
Associate, Singapore

Related Practices & Industries

Otsuka Pharmaceutical Announces Global Strategic Collaboration With Harbour BioMed

June 23, 2025

Cooley advised Otsuka Pharmaceutical, a total healthcare company focused on each individual’s potential to enhance their well-being, on its global strategic collaboration with Harbour BioMed to advance BCMAxCD3 bispecific T-cell engagers for treating autoimmune diseases.

Read more

Related contacts

Jennifer Raab
Partner, Palo Alto
Alison Freeman-Gleason
Of Counsel, Seattle
Rachel Thorn
Of counsel, New York
Zack Gong
Associate, Shanghai
Freddy Yip
Associate, Hong Kong
Jonathan Kaufman
Associate, Palo Alto
Natasha Leskovsek
Of Counsel, Washington, DC
Robert Eisenbach
Of Counsel, San Francisco
Amanda Pacheco
Associate, Palo Alto

Related Practices & Industries

Hengrui Pharmaceuticals Announces License Agreement With Merck KGaA

April 8, 2025

Cooley advised Jiangsu Hengrui Pharmaceuticals (Hengrui Pharma), a global pharmaceutical company focused on scientific and technological innovation, on its exclusive license agreement with Merck KGaA, Darmstadt, Germany for the commercialization in mainland China of SHR7280, an oral small-molecule gonadotropin-releasing hormone receptor antagonist, for indications including medical-assisted reproduction and gynecology.

Read more

Related contacts

Alan W. Tamarelli
Partner, New York
Freddy Yip
Associate, Hong Kong
Caroline Vu
Special Counsel, Palo Alto
Letian Wei
Legal Consultant, Shanghai
Marc Suskin
Partner, New York
Sharon Connaughton
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Rebecca Ross
Special Counsel, Washington, DC
Bin Wang
Special Counsel, Palo Alto
Robert Eisenbach
Of Counsel, San Francisco
Natasha Leskovsek
Of Counsel, Washington, DC
Jiqiang Lin
Associate, New York
Amanda Pacheco
Associate, Palo Alto

Related Practices & Industries

Puhe BioPharma Announces Global License Agreement With Bayer

March 26, 2025

Cooley advised Puhe BioPharma, a biotechnology company dedicated to the research and development of innovative small-molecule precision therapeutics, on its global license agreement with Bayer for Puhe BioPharma’s oral, small-molecule protein arginine methyltransferase 5 inhibitor that selectively targets metabolic enzyme 5’-deoxy-5’-methylthioadenosine phosphorylase-deleted tumors.

Read more

Related contacts

Lila Hope
Partner, Palo Alto
Freddy Yip
Associate, Hong Kong
David Burns
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Amanda Pacheco
Associate, Palo Alto

Related Practices & Industries

Chimerix Announces Acquisition by Jazz Pharmaceuticals for $935 Million

March 5, 2025

Cooley advised Chimerix (Nasdaq: CMRX), a biopharmaceutical company with a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, on its definitive agreement to be acquired by Jazz Pharmaceuticals (Nasdaq: JAZZ) for $8.55 per share in cash – totaling approximately $935 million.

Read more

Related contacts

Jason Kent
Partner, New York
Kevin Cooper
Partner, New York
Nathan Baum
Special Counsel, New York
Jamie Leigh
Partner, San Francisco
Izzy Lubarsky
Partner, New York
Susan Choy
Associate, New York
Charlotte Yin
Associate, New York
Angela Kim
Associate, New York
Jane Adams
Partner, San Diego
Christophe Beauduin
Partner, New York
Ross Eberly
Partner, Santa Monica
Stella Sarma
Partner, Brussels
Natasha Leskovsek
Of Counsel, Washington, DC
Juliana Finley
Associate, Santa Monica
Elizabeth Galvin
Associate, Boston
Carly E. Gibbons
Associate, Chicago
Nathaniel Hearn Jr.
Associate, Chicago
Calvin Lee
Associate, New York
Joseph Perry
Associate, Reston
Greg Reith
Associate, Washington, DC
Freddy Yip
Associate, Hong Kong
Drue Anne Koons
Paralegal Specialist, San Diego

Related Practices & Industries

View more

Admissions and credentials

Hong Kong